Literature DB >> 28884206

Neonatal congenital lung tumors - the importance of mid-second-trimester ultrasound as a diagnostic clue.

Stephan L Waelti1, Laurent Garel2, Dorothée Dal Soglio3, Françoise Rypens1, Michael Messerli4, Josée Dubois1.   

Abstract

BACKGROUND: The differential diagnosis for primary lung masses in neonates includes a variety of developmental abnormalities; it also consists of the much rarer congenital primary lung tumors: cystic pleuropulmonary blastoma (cystic PPB), fetal lung interstitial tumor (FLIT), congenital peribronchial myofibroblastic tumor (CPMT), and congenital fibrosarcoma. Radiologic differentiation between malformations and tumors is often very challenging.
OBJECTIVE: The objective was to establish distinctive features between developmental pulmonary abnormalities and primary lung tumors.
MATERIALS AND METHODS: We conducted a retrospective study of 135 congenital lung lesions at a university mother and child center over a period of 10 years (2005-2015). During this time, we noted four tumors (two cystic PPBs and two FLITs) and 131 malformations. We recorded the following parameters: timing of conspicuity in utero (mid-second trimester, third trimester, or not seen prenatally), presence of symptoms at birth, prenatal and perinatal radiologic findings, and either histological diagnoses by pathology or follow-up imaging in non-operated cases.
RESULTS: All lesions except the four tumors were detected during mid-second-trimester ultrasound. In none of the tumors was any pulmonary abnormality found on the mid-second-trimester sonogram, contrary to the developmental pulmonary abnormalities.
CONCLUSION: The timing of conspicuity in utero appears to be a key feature for the differentiation between malformations and tumors. Lesions that were not visible at the mid-second-trimester ultrasound should be considered as tumor. A cystic lung lesion in the context of a normal mid-second-trimester ultrasound is highly suggestive of a cystic PPB. Differentiating the types of solid congenital lung tumors based upon imaging features is not yet feasible.

Entities:  

Keywords:  Computed tomography; Fetus; Lungs; Malformations; Neonates; Radiography; Tumors; Ultrasound

Mesh:

Year:  2017        PMID: 28884206     DOI: 10.1007/s00247-017-3953-3

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  42 in total

Review 1.  New concepts in the pathology of congenital lung malformations.

Authors:  Claire Langston
Journal:  Semin Pediatr Surg       Date:  2003-02       Impact factor: 2.754

2.  [Congenital pulmonary fibrosarcoma. Differential diagnosis of infantile pulmonary spindle cell tumors].

Authors:  C Kuhnen; D Harms; K H Niessen; T Diehm; K M Müller
Journal:  Pathologe       Date:  2001-03       Impact factor: 1.011

3.  Prenatal presentation and outcome of children with pleuropulmonary blastoma.

Authors:  Douglas N Miniati; Murali Chintagumpala; Claire Langston; Megan K Dishop; Oluyinka O Olutoye; Jed G Nuchtern; Darrell L Cass
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

Review 4.  Fetal hydrops associated with congenital pulmonary myofibroblastic tumor.

Authors:  Tsuguhiro Horikoshi; Akihiko Kikuchi; Yasuhiro Matsumoto; Mikiko Tatematsu; Kentaro Takae; Yoshifumi Ogiso; Masahiro Nakayama; Nobuya Unno
Journal:  J Obstet Gynaecol Res       Date:  2005-12       Impact factor: 1.730

5.  Congenital peribronchial myofibroblastic tumor: comparison of fetal and postnatal morphology.

Authors:  Alison R Huppmann; Cheryl M Coffin; Andrew C Hoot; Samir Kahwash; Bruce R Pawel
Journal:  Pediatr Dev Pathol       Date:  2010-04-05

6.  Fetal lung interstitial tumor: a cause of late gestation fetal hydrops.

Authors:  David A Lazar; Darrell L Cass; Megan K Dishop; Karolina Adam; Olutoyin A Olutoye; Nancy A Ayres; Christopher I Cassady; Oluyinka O Olutoye
Journal:  J Pediatr Surg       Date:  2011-06       Impact factor: 2.545

7.  Fetal lung interstitial tumor (FLIT): A proposed newly recognized lung tumor of infancy to be differentiated from cystic pleuropulmonary blastoma and other developmental pulmonary lesions.

Authors:  Megan K Dishop; Eileen M McKay; Portia A Kreiger; John R Priest; Gretchen M Williams; Claire Langston; Jason Jarzembowski; Mariko Suchi; Louis P Dehner; D Ashley Hill
Journal:  Am J Surg Pathol       Date:  2010-12       Impact factor: 6.394

8.  Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry.

Authors:  Yoav H Messinger; Douglas R Stewart; John R Priest; Gretchen M Williams; Anne K Harris; Kris Ann P Schultz; Jiandong Yang; Leslie Doros; Philip S Rosenberg; D Ashley Hill; Louis P Dehner
Journal:  Cancer       Date:  2014-09-10       Impact factor: 6.860

9.  Congenital infantile fibrosarcoma: review of imaging features.

Authors:  Kelly E Ainsworth; Govind B Chavhan; Abha A Gupta; Sevan Hopyan; Glenn Taylor
Journal:  Pediatr Radiol       Date:  2014-04-06

10.  Primary bronchopulmonary leiomyosarcoma in childhood.

Authors:  J F Jimenez; E O Uthman; J W Townsend; E S Gloster; J J Seibert
Journal:  Arch Pathol Lab Med       Date:  1986-04       Impact factor: 5.534

View more
  4 in total

Review 1.  Fetal ultrasound and magnetic resonance imaging: a primer on how to interpret prenatal lung lesions.

Authors:  Niamh C Adams; Teresa Victoria; Edward R Oliver; Julie S Moldenhauer; N Scott Adzick; Gabrielle C Colleran
Journal:  Pediatr Radiol       Date:  2020-11-30

Review 2.  Congenital lung lesions: a radiographic pattern approach.

Authors:  Alexander Maad El-Ali; Naomi A Strubel; Shailee V Lala
Journal:  Pediatr Radiol       Date:  2021-10-30

Review 3.  Imaging of DICER1 syndrome.

Authors:  R Paul Guillerman; William D Foulkes; John R Priest
Journal:  Pediatr Radiol       Date:  2019-10-16

4.  Fetal lung interstitial tumor: An uncommon pediatric pulmonary neoplasm.

Authors:  Saloni Naresh Shah; N Geetha; Radhakrishnan Satheesan; Ashok Parameswaran
Journal:  Lung India       Date:  2021 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.